Home › Forums › Pharmacovigilance Forum › Personal liability of QPPV for UK
Dear all
During the October 2020 PV Webinar, the MHRA confirmed in a verbal statement that there wouldn’t be any personal legal liability associated with the UK QPPV role and any penalties would sit with the MAH.
Our company has plans to continue to use our current EU QPPV also as QPPV for the UK. We’ve been advised by our QPPV that EFPIA are currently discussing the issue and some QPPVs disagree with the MHRA’s statement.
If they’re correct, the UK QPPV would need a UK professional indemnity insurance from 1st Jan 2021. We’d be interested to see if other companies have discussed this or/and have made any arrangements already (or perhaps raised this with the MHRA/ABPI or their legal departments).
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.